In short, VersAI™ is much greener AI. It’s truly remarkable that a pharmaceutical company is at the forefront of developing fundamental new AI technology that outperforms industry titans like Google, ...

New Zealand’s largest banks have reduced their lending exposure to the fossil fuel sector by more than $100 million in just a year, a reduction of more than 10% between 2023 and 2024. The figure ...

OKYO Pharma (OKYO) has been notified that the CEO Gary Jacob has purchased 10,000 of the Company’s ordinary shares on NASDAQ at a price of $1.04 per share. The company said, “We have also been ...

BILLIONAIRE Li Ka-shing’s port business in Panama said it’s committed to operating in the country, after local authorities launched an audit of the company amid concerns raised by US President Donald ...

If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $175.00. The company’s shares closed ...

But MPs warned that the regulator received 75 per cent of its funding from pharmaceutical companies and was too close to the industry to be truly independent when scrutinising safety and ...

In 2018, 16 of the top 20 publicly traded pharmaceutical players globally reported year-on-year growth in their revenue, with three companies – Takeda, Celgene (currently under a merger ...

The pharma companies made drugs that could help patients and spent lots of time telling doctors which drugs to give to who. Then payers came along and started scrutinising how much was being spent ...

The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...